Skip to main content

Mitchell Wolfe Krucoff CV

Professor of Medicine
Medicine, Cardiology
Duke Box 3968, Durham, NC 27710
508 Fulton St A3006, Durham, NC 27705
CV

Current Duke Appointments & Affiliations


Professor of Medicine · 2005 - Present Medicine, Cardiology, Medicine
Member in the Duke Clinical Research Institute · 2006 - Present Duke Clinical Research Institute, Institutes and Centers

Recent News Items


Published July 6, 2016
Dr. Mitchell Krucoff comments: Abbott wins U.S. approval for stent that absorbs into body

View All News Items

Recent Scholarly Works


Timing of Bleeding and Ischemic Events in High-Bleeding Risk Patients Treated With 1-Month DAPT.

Journal article JACC Cardiovasc Interv · July 27, 2026 BACKGROUND: Understanding the concomitant evolution of bleeding vs ischemic risk after percutaneous coronary intervention (PCI) in patients at high bleeding risk (HBR) treated with 1-month dual antiplatelet therapy (DAPT) would help optimize dynamic treatm ... Full text Link to item Cite

Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention.

Journal article Eur J Prev Cardiol · July 23, 2026 AIMS: In patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI), abbreviated dual antiplatelet therapy (DAPT) has been shown to reduce bleeding without increasing ischemic risk. However, the optimal duration in specific su ... Full text Link to item Cite

Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR Score.

Journal article JACC Cardiovasc Interv · July 13, 2026 BACKGROUND: Among high-bleeding risk (HBR) patients undergoing coronary stenting, abbreviated dual antiplatelet therapy (DAPT) reduces bleeding without ischemic risk trade-off; whether these benefits persist across the entire spectrum of bleeding risk has ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period

ResearchCo Investigator · Awarded by Food and Drug Administration · 2022 - 2024

PASSION CVR Think Tank

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Boston Scientific Corporation · 2024 - 2024

CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study

ResearchProgram Director · Awarded by Food and Drug Administration · 2019 - 2022

View All Grants

Education


The George Washington University · 1980 M.D.

External Links


MWK - CV - 2019